Onyangunga Onankoy A, Naicker Thajasvarie, Moodley Jagidesa
Optics and Imaging Centre, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Women's Health and HIV Research Group, Department of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
S Afr J Infect Dis. 2020 Apr 30;35(1):115. doi: 10.4102/sajid.v35i1.115. eCollection 2020.
Despite the availability of screening guidelines and effective treatment for maternal syphilis (MS), its prevalence remains high and is re-emerging in many parts of the world. This might be because of varying screening tests and algorithms for the laboratory diagnosis and treatment of syphilis. In addition, HIV co-infection may compromise the elimination of MS. The present study is a clinical audit of the prevalence of MS in KwaZulu-Natal, South Africa, using the 'Traditional Algorithm' screening.
This was a retrospective audit in which data on syphilis testing were obtained over a 1-year period (2016) at a large regional hospital in South Africa. The standard screening test at the study site was the non-treponemal antigen, rapid plasma reagin (RPR). Data on the prevalence of MS and comorbidity with HIV infection were analysed.
There were 10 680 deliveries in the study period of which 118 were RPR reactive, giving an MS prevalence of 1.1%. MS occurred predominantly in the age groups < 18 and > 35 years ( = 0.001). The prevalence of HIV infection was 41.2% ( = 4451). Seventy-two (61.0%) had both HIV and MS infection, whilst 46 (39.0%) had discordant results ( = 0.001).
We report an increase in the prevalence of MS compared to previous South African National Antenatal Syphilis Surveillance studies. This may be because of the prozone effect caused by HIV infection on the sensitivity of the RPR. We propose a change in MS screening, using a Rapid DUO (Dual HIV and syphilis point of care test) and Reverse Algorithm for screening that could improve the sensitivity, detection and management of both diseases.
尽管有针对孕产妇梅毒(MS)的筛查指南和有效治疗方法,但其患病率仍然很高,并且在世界许多地区再度出现。这可能是由于梅毒实验室诊断和治疗的筛查试验及算法各不相同。此外,HIV合并感染可能会影响MS的消除。本研究是一项在南非夸祖鲁-纳塔尔省对MS患病率进行的临床审计,采用“传统算法”进行筛查。
这是一项回顾性审计,在南非一家大型地区医院收集了为期1年(2016年)的梅毒检测数据。研究地点的标准筛查试验是非梅毒螺旋体抗原快速血浆反应素试验(RPR)。分析了MS患病率及与HIV感染合并症的数据。
研究期间共有10680例分娩,其中118例RPR呈反应性,MS患病率为1.1%。MS主要发生在<18岁和>35岁年龄组(P = 0.001)。HIV感染患病率为41.2%(n = 4451)。72例(61.0%)同时感染了HIV和MS,而46例(39.0%)结果不一致(P = 0.001)。
与之前南非国家产前梅毒监测研究相比,我们报告MS患病率有所上升。这可能是由于HIV感染对RPR敏感性产生的前带效应。我们建议改变MS筛查方法,采用快速双联检测(HIV和梅毒即时检测)及反向算法进行筛查,这可能会提高两种疾病的敏感性、检测率和管理水平。